RFT-19039-07283
4 vaccinations
1 coded response
39 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 191 / PA
- Registered
- 2020-12-22
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
QXT-22941-09642
Child or adolescent in my care · Male · 2022-07-01
Timeline
-
2020-12-22
Registered in v-safe
-
2020-12-22
Dose 1 — Pfizer-BioNTech
- 2020-12-22
-
2020-12-23
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain, Redness · Headache, Muscle or body achesAdult check-in
- 2020-12-24
- 2020-12-25
- 2020-12-26
- 2020-12-27
- 2020-12-28
- 2020-12-29
- 2021-01-06
-
2021-01-08
Dose 2 — Pfizer-BioNTech
- 2021-01-08
-
2021-01-09
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-09
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities1 call case(s)
- 2021-01-10
- 2021-01-11
- 2021-01-12
- 2021-01-13
- 2021-01-14
- 2021-01-15
- 2021-01-22
-
2021-01-26
Call successfulDoes not wish to fill out VAERS report
- 2021-01-29
- 2021-02-05
- 2021-02-12
- 2021-02-19
- 2021-04-09
- 2021-07-09
-
2021-11-19
Dose 3 — Pfizer-BioNTech
- 2022-01-08
-
2022-07-30
Dose 4 — Moderna
- 2022-07-30
-
2022-07-31
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Muscle or body achesAdult check-in
-
2022-08-01
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain · Chills, Joint pains, Muscle or body achesAdult check-in
- 2022-08-02
- 2022-08-03
- 2022-08-04
- 2022-08-05
- 2022-08-06
- 2022-08-13
- 2022-08-20
- 2022-08-27
- 2022-09-05
- 2022-09-10
-
2022-10-30
Survey response — 3 months, dose 4MedDRA: Upper respiratory tract infection — Feeling: Poor · Be unable to work or attend schoolFree text: Upper respiratory tract infectionMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-22 | Pfizer-BioNTech | |
| 2 | 2021-01-08 | Pfizer-BioNTech | |
| 3 | 2021-11-19 | Pfizer-BioNTech | No |
| 4 | 2022-07-30 | Moderna | No |
Call center
1 call center case
1 successful
Free text
Release 12 — 3 months, dose 4
Symptoms: Upper respiratory tract infection
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Upper respiratory tract infection | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release